Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape.

This conversation was record April 10, 2026

Lisa Salberg and Dr. Alex de Feria walk through how patients can stay proactive with hypertrophic cardiomyopathy—from annual testing and symptom tracking to understanding when to act. They break down real-world decision making, hidden symptoms, and how evolving care strategies can help patients stay ahead of their condition.

This conversation was recorded March 26, 2026.

Lisa Salberg and Dr. Marty Maron break down new research reshaping how HCM is treated, from long-standing beta blockers to emerging targeted therapies. They also walk through arrhythmia risks, monitoring, and prevention—giving patients a clearer roadmap for managing symptoms and long-term outcomes in a rapidly changing care landscape.

Lisa Salberg sits down with Senator Anthony Bucco to discuss why Heart Month and knowing your family heart health history can save lives. They explore New Jersey’s leadership in cardiac screening laws, the importance of early detection for HCM, and ongoing efforts to improve insurance access and patient protections.

This conversation was recorded Feb. 20, 2026.

Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.

This conversation was recorded Feb. 20, 2026.

Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.

This conversation was recorded Feb. 13, 2026

Host Lisa Salberg talks with author Dr. Matt Martinez about living with hypertrophic cardiomyopathy while balancing family, career, and advocacy. The conversation explores personal perspective, patient empowerment, and how sharing lived experience can help others better understand and navigate an HCM diagnosis.

This conversation was recorded Feb. 6, 2026.

Host Lisa Salberg talks with author and educator Dr. Mary Massey about the loss of her son to sudden cardiac arrest and the book she wrote to honor his life and help other families understand hypertrophic cardiomyopathy. Their conversation explores grief, genetic risk, ongoing screening, and how sharing one story can help protect others.

This conversation was recorded Feb. 2, 2026.

Host Lisa Salberg is joined by Minnesota State Senator Carla Nelson to discuss her personal journey with hypertrophic cardiomyopathy and how that experience shaped her advocacy for cardiac screening and education. They explore the role of legislation, family heart health history, and public awareness in helping identify HCM earlier and protecting future generations.

This conversation was recorded Feb. 2, 2026

Host Lisa Salberg is joined by Dr. Milind Desai of Cleveland Clinic to discuss new research challenging how hypertrophic cardiomyopathy patients define “asymptomatic.” They break down what long-term data and stress testing reveal about hidden symptoms, why follow-up matters even when you feel well, and how new therapies are reshaping care during a rapidly evolving era in HCM treatment.

This conversation was recorded Jan. 30, 2026.